KRRO
Korro Bio, Inc.
10.00$
-15.1%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
Korro Bio, Inc. (KRRO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -79 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -15 | -17 | 34 | -45 | -32 | -54 | -67 | -60 | -79 | |
| 0.5 | 0.7 | 0.8 | 1.6 | 1.6 | 2.5 | 3.6 | 3.6 | 3.8 | |
| – | – | – | – | 0.8 | 1.1 | 2.4 | 4.5 | 7.7 | |
| 0.3 | 0.8 | 49 | -30 | 0.9 | -0.6 | 4.3 | 14 | -4.4 | |
| 1.9 | 0.4 | 1.1 | 6.7 | 4.4 | 5.2 | 7.8 | 18 | 0.5 | |
| -1.9 | 3.3 | -18 | 10 | -40 | 11 | 11 | -123 | 44 | |
| 28 | 38 | 142 | 57 | 116 | 0.0 | 188 | 69 | 0.7 | |
| 12 | 24 | 158 | 20 | 44 | -43 | 132 | -114 | -34 | |
| -16 | -17 | 33 | -52 | -37 | -59 | -75 | -78 | -79 |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.